Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
SOLI - Solithromycin Pediatric Development Program (Phase 2/3 start up)- MOD 2
Clinical Trial Grant
Duke Scholars
Principal Investigator
Michael Cohen-Wolkowiez
Pediatrics, Infectious Diseases
Awarded By
Cempra Pharmaceuticals, Inc.
Start Date
April 13, 2016
End Date
June 30, 2017
Awarded By
Cempra Pharmaceuticals, Inc.
Start Date
April 13, 2016
End Date
June 30, 2017
